Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-16

Clinical Trial Update: A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine [Phase 3]

View source ↗

Summary

A Phase 3 study assessed the safety and efficacy of albiglutide in combination with insulin glargine in adults with type 2 diabetes, with results posted in 2014…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albiglutide (albiglutide)
  • Insulin Glargine (insulin glargine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2014-07-16